{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:24:33Z","timestamp":1789035873522,"version":"build-2803163510"},"reference-count":45,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100005972","name":"deutsche krebshilfe","doi-asserted-by":"publisher","award":["70113910"],"award-info":[{"award-number":["70113910"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Palliat Med"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Off-label use of drugs is an integral part of everyday clinical practice in palliative medicine. However, it is associated with many uncertainties, that is, drug therapy safety or legal issues including cost coverage. Healthcare professionals often lack time and resources for comprehensive literature search and patient-specific risk-benefit analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>The aim of this project is to develop, evaluate and rate agreement\/disagreement on treatment recommendations for off-label use in adult palliative medicine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Online Delphi study with two rounds each to rate agreement\/disagreement with treatment recommendations for off-label use in adult palliative medicine. An international expert panel consisting of physicians, pharmacists and nurses working in palliative care evaluated previously developed recommendations based on the best available evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:\/participants:<\/jats:title>\n                    <jats:p>Professionals (physicians, pharmacists, nursing staff) working in inpatient and home palliative care involved in the medication process were recruited as experts to participate. Between 64 and 75 experts participated in the first two Delphi studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 64\/68 recommendations on 21 drugs and 14 applications were agreed upon. Topics related to routes of administration as well as indications for sialorrhea, bronchorrhea, xerostomia, pruritus, singultus, fistula, gastroparesis and hot flashes. Recommendations that reached consensus are available to health care professionals via a free of charge database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>For many off-label use applications, it is likely that there will be no registration studies and therefore no drug approvals in the future. The consensus-based recommendations are intended to facilitate individual treatment planning for prescribers and to enable a more reflected handling of off-label use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02692163251323123","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T07:46:56Z","timestamp":1742024816000},"page":"530-542","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Off-label drug use in palliative medicine: Delphi study for the consensus of evidence-based treatment recommendations"],"prefix":"10.1177","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4053-6012","authenticated-orcid":false,"given":"Stefanie","family":"P\u00fcgge","sequence":"first","affiliation":[{"name":"Department of Palliative Medicine, LMU University Hospital, Ludwig-Maximilians-University in Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2500-3044","authenticated-orcid":false,"given":"Aleksandra","family":"Dukic-Ott","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, LMU University Hospital, Ludwig-Maximilians-University in Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Baumg\u00e4rtel","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, LMU University Hospital, Ludwig-Maximilians-University in Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9545-8297","authenticated-orcid":false,"given":"Saskia","family":"J\u00fcnger","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Hochschule Bochum, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0958-3041","authenticated-orcid":false,"given":"Claudia","family":"Bausewein","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, LMU University Hospital, Ludwig-Maximilians-University in Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7655-0306","authenticated-orcid":false,"given":"Constanze","family":"R\u00e9mi","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, LMU University Hospital, Ludwig-Maximilians-University in Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,3,15]]},"reference":[{"key":"e_1_3_3_2_2","unstructured":"European Medicines Agency (EMA). Guideline on good pharmacovigilance practices (GVP) Annex I \u2013 definitions (Rev 4) https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-good-pharmacovigilance-practices-annex-i-definitions-rev-4_en.pdf (2017 accessed 18 March 2024)."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-018-0186-y"},{"key":"e_1_3_3_4_2","first-page":"776","article-title":"Off-Label medication use in children, more common than we think: a systematic review of the literature","volume":"111","author":"Allen HC","year":"2018","unstructured":"Allen HC, Garbe MC, Lees J, et al Off-Label medication use in children, more common than we think: a systematic review of the literature. J Okla State Med Assoc 2018; 111: 776\u2013783.","journal-title":"J Okla State Med Assoc"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2020.06.014"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12507"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100604"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/09699260.2019.1646048"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269216312464263"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2017.03.014"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.04.017"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269216319840602"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2020-002554"},{"key":"e_1_3_3_14_2","unstructured":"R\u00e9mi C Bausewein C. Zum Umgang mit off-label-use in der palliativmedizin https:\/\/www.dgpalliativmedizin.de\/images\/RZ_200219_Offlabel_DS_ONLINE_aktuell_v2.pdf (2020 accessed 18 March 2024)."},{"key":"e_1_3_3_15_2","unstructured":"Leitlinienprogramm Onkologie. Erweiterte S3-Leitlinie Palliativmedizin f\u00fcr Patienten mit einer nicht-heilbaren Krebserkrankung. Langversion 2.2 \u2013 September 2020 AWMF-Registernummer: 128\/001-OL https:\/\/www.leitlinienprogramm-onkologie.de\/fileadmin\/user_upload\/Downloads\/Leitlinien\/Palliativmedizin\/Version_2\/LL_Palliativmedizin_Langversion_2.2.pdf (2020)."},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2019-002165"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-011-1275-9"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0397"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269216317690685"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1055\/a-1397-1019"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1191\/0269216305pm1057oa"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2014.01.007"},{"key":"e_1_3_3_23_2","first-page":"193","article-title":"Reality of evidence-based practice in palliative care","volume":"12","author":"Visser C","year":"2015","unstructured":"Visser C, Hadley G, Wee B. Reality of evidence-based practice in palliative care. Cancer Bio Med 2015; 12: 193\u2013200.","journal-title":"Cancer Bio Med"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1177\/135581969900400410"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-007-0348-2"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00457"},{"key":"e_1_3_3_27_2","unstructured":"WHO. Essential medicine in palliative care: executive summary. 2013 http:\/\/www.who.int\/selection_medicines\/committees\/expert\/19\/applications\/PalliativeCare_8_A_R.pdf"},{"key":"e_1_3_3_28_2","volume-title":"Arzneimitteltherapie in der Palliativmedizin","author":"R\u00e9mi C","year":"2022","unstructured":"R\u00e9mi C, Bausewein C, Wilcock A, et al Arzneimitteltherapie in der Palliativmedizin. 4th ed. M\u00fcnchen: Elsevier Urban and Fischer, 2022.","edition":"4"},{"key":"e_1_3_3_29_2","unstructured":"German Association of the Scientific Medical Societies (AWMF) \u2013 Standing Guidelines Commission. AWMF guidance manual and rules for guideline development http:\/\/www.awmf.org\/leitlinien\/awmf-regelwerk.html (accessed 27 May 2024)."},{"key":"e_1_3_3_30_2","first-page":"598","article-title":"The Delphi method","volume":"22","author":"Iqbal S","year":"2009","unstructured":"Iqbal S, Pipon-Young L. The Delphi method. Psychologist 2009; 22: 598\u2013601.","journal-title":"Psychologist"},{"key":"e_1_3_3_31_2","unstructured":"Deutsche Gesellschaft f\u00fcr Palliativmedizin. Guide to hospices and palliative care (Wegweiser Hospiz- und Palliativversorgung) https:\/\/www.wegweiser-hospiz-palliativmedizin.de\/en. (2019)."},{"key":"e_1_3_3_32_2","volume-title":"LimeSurvey: an open source survey tool","author":"Limesurvey GmbH","unstructured":"Limesurvey GmbH. LimeSurvey: an open source survey tool. Hamburg, Germany: LimeSurvey GmbH."},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.techfore.2012.04.013"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.5662\/wjm.v11.i4.116"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188348"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269216313479843"},{"key":"e_1_3_3_37_2","first-page":"3","article-title":"Potenziell inad\u00e4quate Medikation f\u00fcr \u00e4ltere Menschen: PRISCUS 2.0","volume":"120","author":"Mann N-K","year":"2023","unstructured":"Mann N-K, Mathes T, S\u00f6nnichsen A, et al Potenziell inad\u00e4quate Medikation f\u00fcr \u00e4ltere Menschen: PRISCUS 2.0. Dtsch Arztebl Int 2023; 120: 3\u201310.","journal-title":"Dtsch Arztebl Int"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-023-01024-6"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12060"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-022-01312-8"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-023-01243-z"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-021-01613-7"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.zefq.2022.08.007"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2736"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-658-01928-0"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-658-18755-2"}],"container-title":["Palliative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02692163251323123","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02692163251323123","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02692163251323123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:37:18Z","timestamp":1777660638000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02692163251323123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1177\/02692163251323123"],"URL":"https:\/\/doi.org\/10.1177\/02692163251323123","relation":{},"ISSN":["0269-2163","1477-030X"],"issn-type":[{"value":"0269-2163","type":"print"},{"value":"1477-030X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,15]]}}}